Breaking News Instant updates and real-time market news.

2020-12-03 16:36:48 STRO Sutro Biopharma $17.01 / +0.66 (+4.04%) 16:36 12/03/20 12/03 16:36 12/03/20 16:36	Sutro Biopharma's saw 'encouraging' phase 1 data for STRO-002 in ovarian cancer Sutro Biopharma provided a clinical update from the company's ongoing dose-escalation Phase 1 study of STRO-002, a folate receptor alpha targeting antibody-drug conjugate, for patients with ovarian cancer. The dose-escalation study included 34 patients treated with clinically active dose levels, 2.9 mg/kg or higher, of which 31 patients had post-baseline scans and were evaluable for RECIST responses. At the data cutoff of October 30, 2020, median time on treatment was 19 weeks and 10 patients remained on treatment. Results out of 31 evaluable patients included: 10 patients met RECIST criteria for response. Of which, 1 patient achieved a complete response and 9 patients achieved a partial response PR; 23 patients or 74% achieved disease control at 12 weeks; 18 patients or 58% achieved disease control at 16 weeks; 4 patients or 13% were on treatment for 52 weeks. 3 patients remained on treatment beyond 64 weeks. STRO-002 continues to be well-tolerated and 86% of all treatment-emergent adverse events (AEs) were Grade 1 or 2.	03 Dec 03 Dec 12 May
STRO Sutro Biopharma $17.01 / +0.66 (+4.04%) 12/02/20 Stifel Sutro Biopharma initiated with a Buy at Stifel 11/06/20 Piper Sandler Sutro Biopharma price target raised to $22 from $20 at Piper Sandler 09/18/20 Piper Sandler Piper Sandler lays out next potential takeover targets in oncology 09/02/20 Jefferies Sutro Biopharma initiated with a Buy at Jefferies

2020-12-03 16:36:48

STRO

Sutro Biopharma

$17.01 / +0.66 (+4.04%)

16:36

12/03/20

12/03

16:36

12/03/20

16:36

Sutro Biopharma's saw 'encouraging' phase 1 data for STRO-002 in ovarian cancer

Sutro Biopharma provided a clinical update from the company's ongoing dose-escalation Phase 1 study of STRO-002, a folate receptor alpha targeting antibody-drug conjugate, for patients with ovarian cancer. The dose-escalation study included 34 patients treated with clinically active dose levels, 2.9 mg/kg or higher, of which 31 patients had post-baseline scans and were evaluable for RECIST responses. At the data cutoff of October 30, 2020, median time on treatment was 19 weeks and 10 patients remained on treatment. Results out of 31 evaluable patients included: 10 patients met RECIST criteria for response. Of which, 1 patient achieved a complete response and 9 patients achieved a partial response PR; 23 patients or 74% achieved disease control at 12 weeks; 18 patients or 58% achieved disease control at 16 weeks; 4 patients or 13% were on treatment for 52 weeks. 3 patients remained on treatment beyond 64 weeks. STRO-002 continues to be well-tolerated and 86% of all treatment-emergent adverse events (AEs) were Grade 1 or 2.

03
Dec
03
Dec

12
May

STRO Sutro Biopharma

$17.01 / +0.66 (+4.04%)

12/02/20 Stifel: Sutro Biopharma initiated with a Buy at Stifel

11/06/20 Piper Sandler: Sutro Biopharma price target raised to $22 from $20 at Piper Sandler

09/18/20 Piper Sandler: Piper Sandler lays out next potential takeover targets in oncology

09/02/20 Jefferies: Sutro Biopharma initiated with a Buy at Jefferies

TODAY'S FREE FLY STORIES

Conference/Events	MKM Partners entertainment/video analysts hold analyst/industry conference call » 13:09 01/21/21 01/21 13:09 01/21/21 13:09 Entertainment/Video Games… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Hot Stocks	BlackRock board approves 14% boost in quarterly dividend to $4.13 per share » 13:08 01/21/21 01/21 13:08 01/21/21 13:08 BLK BlackRock $741.00 / -0.685 (-0.09%) BlackRock announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options BLK BlackRock $741.00 / -0.685 (-0.09%) 01/14/21 BlackRock to make an investment in Clarity AI 01/14/21 BlackRock sees 2021 as-adjusted operating margin generally in line with 2020 01/14/21 BlackRock planning for possibility of lower securities lending revenue in 2021 01/14/21 BlackRock CEO says 'we begin 2021 well-positioned' BLK BlackRock $741.00 / -0.685 (-0.09%) 01/19/21 RBC Capital PNC Financial price target raised to $161 from $135 at RBC Capital 01/15/21 BMO Capital BlackRock price target raised to $715 from $709 at BMO Capital 01/15/21 Deutsche Bank BlackRock price target raised to $838 from $835 at Deutsche Bank 01/15/21 Barclays BlackRock price target raised to $850 from $800 at Barclays BLK BlackRock $741.00 / -0.685 (-0.09%) 01/14/21 BlackRock reports Q4 adjusted EPS $10.18, consensus $9.14 01/13/21 Notable companies reporting before tomorrow's open 10/13/20 BlackRock reports Q3 adjusted EPS $9.22, consensus $7.77 10/12/20 Notable companies reporting before tomorrow's open 13 May BLK BlackRock $741.00 / -0.685 (-0.09%) 13:00 Today BlackRock to make bitcoin futures eligible investment in two funds, Reuters says 01/11/21 BlackRock selling stakes in sanctioned Chinese mobile companies, Bloomberg says 01/11/21 BlackRock pauses donations to public officials, Bloomberg reports 01/05/21 Rivian close to raising funds at $25B valuation, Bloomberg says BLK BlackRock $741.00 / -0.685 (-0.09%) 01/14/21 Fly Intel: Pre-market Movers 12/06/20 Opening Day: Kinnate Biopharma soars in trading debut 10/13/20 Fly Intel: Wall Street's top stories for Tuesday 10/13/20 Fly Intel: Wall Street's top stories at midday 02/24/21 22nd Annual Virtual Financial Services Forum BLK BlackRock $741.00 / -0.685 (-0.09%) 10/13/20 Early notable gainers among liquid option names on October 13th
General news	10-Yr TIPS Auction Coupon Rate data reported » 13:08 01/21/21 01/21 13:08 01/21/21 13:08 10-Yr TIPS Auction Coupon… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
General news	10-Yr TIPS Auction Total Amount data reported » 13:08 01/21/21 01/21 13:08 01/21/21 13:08 10-Yr TIPS Auction Total… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Options	Electrameccanica Vehicles Corp call volume above normal and directionally bullish » 13:05 01/21/21 01/21 13:05 01/21/21 13:05 SOLO ElectraMeccanica $8.00 / +0.43 (+5.68%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals Options SOLO ElectraMeccanica $8.00 / +0.43 (+5.68%) 01/15/21 ElectraMeccanica increases retail footprint into three cities 12/28/20 ElectraMeccanica provides update on opening of six retail locations 11/20/20 Citron calls ElectraMeccanica 'complete joke,' puts $2 target on shares 10/29/20 ElectraMeccanica announces arrival of first production SOLO EVs, store openings SOLO ElectraMeccanica $8.00 / +0.43 (+5.68%) 12/16/20 Stifel ElectraMeccanica initiated with a Buy at Stifel 12/16/20 Colliers ElectraMeccanica initiated with a Buy at Colliers 11/23/20 Roth Capital ElectraMeccanica price target raised to $12.25 from $7.50 at Roth Capital 10/29/20 Roth Capital Roth reiterates Buy rating on ElectraMeccanica after first deliveries from China SOLO ElectraMeccanica $8.00 / +0.43 (+5.68%) 11/20/20 Citron puts $2 price target on 'complete joke' ElectraMeccanica SOLO ElectraMeccanica $8.00 / +0.43 (+5.68%) 01/12/21 Unusually active option classes on open January 12th 01/11/21 Electrameccanica Vehicles Corp call volume above normal and directionally bullish 12/17/20 Electrameccanica Vehicles Corp call volume above normal and directionally bullish 12/07/20 Electrameccanica Vehicles Corp call volume above normal and directionally bullish

Hot Stocks	Carnival's Princess Cruises announces sale of Pacific Princess » 13:02 01/21/21 01/21 13:02 01/21/21 13:02 CCL Carnival $20.55 / -0.23 (-1.11%) Princess Cruises, part of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate Periodicals On The Fly Options CCL Carnival $20.55 / -0.23 (-1.11%) 01/19/21 Carnival CEO sells over 62,000 common shares 01/19/21 Carnival CFO sells over 49,000 common shares 01/11/21 Carnival: Unable to predict when entire fleet will return to normal operations 01/11/21 Carnival: Cumulative advanced bookings for 2H21 within historical range CCL Carnival $20.55 / -0.23 (-1.11%) 01/12/21 Deutsche Bank Carnival price target raised to $16 from $13 at Deutsche Bank 10/30/20 Stifel CDC lifting 'no sail order' a 'clear positive' for cruise liners, says Stifel 10/16/20 Deutsche Bank Deutsche sees Covid newsflow remaining drag on cruise stocks 10/07/20 JPMorgan Royal Caribbean price target raised to $79 from $67 at JPMorgan 02 Apr CCL Carnival $20.55 / -0.23 (-1.11%) 01/11/21 Carnival tells WSJ Q4 sales in tens of millions, consensus $156M 11/13/20 Five people aboard SeaDream cruise ship test positive for COVID, CNN reports 09/30/20 White House planning meeting with cruise line CEOs for Friday, CNBC says 09/30/20 CDC Director Redfield overruled on cruise ship 'no-sail order,' Axios reports CCL Carnival $20.55 / -0.23 (-1.11%) 11/09/20 Fly Intel: Wall Street's top stories at midday 11/09/20 Pfizer, BioNTech lift market as COVID vaccine shows effectiveness 11/09/20 Fly Intel: Pre-market Movers 10/30/20 Fly Intel: Wall Street's top stories for Friday CCL Carnival $20.55 / -0.23 (-1.11%) 01/14/21 Carnival call volume above normal and directionally bullish 12/23/20 Early notable gainers among liquid option names on December 23rd 11/24/20 Early notable gainers among liquid option names on November 24th 11/16/20 Early notable gainers among liquid option names on November 16th
Hot Stocks	CMS Energy raises quarterly dividend to 43.5c per share from 40.75c » 13:01 01/21/21 01/21 13:01 01/21/21 13:01 CMS CMS Energy $57.90 / -0.81 (-1.38%) The board of directors of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events CMS CMS Energy $57.90 / -0.81 (-1.38%) 11/18/20 CMS Energy CEO Patti Poppe to leave, Garrick Rochow to succeed 11/18/20 PG&E names Patricia Poppe as CEO, effective January 4, 2021 10/25/20 Fly Intel: Top five weekend stock stories 07/30/20 CMS Energy reports purchase of 51% ownership stake in Aviator Wind project CMS CMS Energy $57.90 / -0.81 (-1.38%) 11/18/20 Barclays CMS Energy price target raised to $75 from $65 at Barclays 10/23/20 Mizuho CMS Energy price target raised to $67 from $61 at Mizuho 09/21/20 Barclays CMS Energy downgraded to Equal Weight from Overweight at Barclays 07/09/20 BMO Capital CMS Energy initiated with an Outperform at BMO Capital CMS CMS Energy $57.90 / -0.81 (-1.38%) 10/29/20 CMS Energy sees 2021 adjusted EPS $2.86-$2.86, consensus $2.85 10/29/20 CMS Energy backs FY20 adj EPS view $2.64-$2.68, consensus $2.66 10/29/20 CMS Energy reports Q3 adjusted EPS 77c, consensus 72c 08/03/20 CMS Energy backs FY20 adjusted EPS view $2.64-$2.68, consensus $2.64 CMS CMS Energy $57.90 / -0.81 (-1.38%) 10/24/20 NextEra, Xcel Energy among utility stocks offering safe yields, Barron's says 03/01/21 26th Annual Energy Virtual Summit 02/04/21 CMS Energy - CMS
Recommendations	Altria price increase doesnt address ongoing concerns, says Goldman Sachs » 13:01 01/21/21 01/21 13:01 01/21/21 13:01 MO Altria Group $41.81 / -0.28 (-0.67%) Following… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MO Altria Group $41.81 / -0.28 (-0.67%) 01/10/21 Fly Intel: Top five weekend stock stories 12/10/20 Minnesota AG adds Altria as defendant in Juul marketing lawsuit 12/07/20 Altria confirms FDA authorizes sale of IQOS 3 in U.S. 11/12/20 Altria converts non-Voting shares in JUUL to voting shares amid FTC litigation MO Altria Group $41.81 / -0.28 (-0.67%) 01/19/21 Bernstein Altria Group initiated with an Outperform at Bernstein 12/15/20 RBC Capital Altria's R.J. Reynolds, Santa Fe Natural increasing prices, says RBC Capital 12/11/20 Piper Sandler Altria Group price target raised to $57 from $47 at Piper Sandler 11/16/20 Jefferies Cronos Group price target lowered to C$5.00 from C$5.60 at Jefferies MO Altria Group $41.81 / -0.28 (-0.67%) 10/30/20 Altria Group narrows FY20 adj. EPS view to $4.30-$4.38 from $4.21-$4.38 10/30/20 Altria Group reports Q3 adj. EPS $1.19, consensus $1.16 10/29/20 Notable companies reporting before tomorrow's open 10/29/20 Notable companies reporting before tomorrow's open MO Altria Group $41.81 / -0.28 (-0.67%) 01/09/21 Some century-old stocks still deliver, Barron's says 10/30/20 Altria Group slashes Juul valuation under $5B, WSJ reports 10/29/20 Juul lowers view of valuation to about $10B, WSJ reports 10/23/20 Judge rejects CA claims against Juul in youth vaping cases, Bloomberg says MO Altria Group $41.81 / -0.28 (-0.67%) 10/30/20 Fly Intel: Pre-market Movers 10/29/20 Fly Intel: Wall Street's top stories for Thursday 08/28/20 Fly Intel: Wall Street's top stories for Friday 07/28/20 Fly Intel: Wall Street's top stories for Tuesday 01/28/21 Altria Group - MO MO Altria Group $41.81 / -0.28 (-0.67%) 12/24/20 Unusually active option classes on open December 24th 12/09/20 Altria Group call volume above normal and directionally bullish 12/08/20 Altria Group call volume above normal and directionally bullish 11/10/20 Altria Group call volume above normal and directionally bullish
Periodicals	BlackRock to make bitcoin futures eligible investment in two funds, Reuters says » 13:00 01/21/21 01/21 13:00 01/21/21 13:00 BLK BlackRock $742.20 / +0.515 (+0.07%) , BTC Bitcoin $0.00 / + (+0.00%) , BITCOIN Bitcoin $0.00 / + (+0.00%) BlackRock intends to add… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options BLK BTC BITCOIN BLK BlackRock $742.20 / +0.515 (+0.07%) 01/14/21 BlackRock to make an investment in Clarity AI 01/14/21 BlackRock sees 2021 as-adjusted operating margin generally in line with 2020 01/14/21 BlackRock planning for possibility of lower securities lending revenue in 2021 01/14/21 BlackRock CEO says 'we begin 2021 well-positioned' BTC Bitcoin $0.00 / + (+0.00%) 01/13/21 DPW Holdings' DPL to provide business loans collateralized by bitcoin, Ethereum 01/11/21 Gundlach says Bitcoin in 'bubble territory' 01/08/21 Bill Miller says bitcoin should be up 50%-100% in next 12-18 months 01/07/21 MicroStrategy jumps 8% to $519.64 as bitcoin tops $40,000 for first time BITCOIN Bitcoin $0.00 / + (+0.00%) 12/21/20 Riot Blockchain buys additional 15,000 Antminers from Bitmain for $35M 12/20/20 Tesla's Musk inquires about moving 'large transactions' to Bitcoin 12/17/20 Coinbase announces confidential submission of draft registration statement 12/03/20 Visa to launch credit card that rewards purchases in bitcoin BLK BTC BITCOIN BLK BlackRock $742.20 / +0.515 (+0.07%) 01/19/21 RBC Capital PNC Financial price target raised to $161 from $135 at RBC Capital 01/15/21 BMO Capital BlackRock price target raised to $715 from $709 at BMO Capital 01/15/21 Deutsche Bank BlackRock price target raised to $838 from $835 at Deutsche Bank 01/15/21 Barclays BlackRock price target raised to $850 from $800 at Barclays BTC Bitcoin $0.00 / + (+0.00%) 01/13/21 Standpoint Research Bitcoin could hit $112,000 this year, says Standpoint Research 01/23/20 Morgan Stanley PayPal acceptance gap widens against Amazon, Bitcoin, says Morgan Stanley BITCOIN Bitcoin $0.00 / + (+0.00%) BLK BTC BITCOIN BLK BlackRock $742.20 / +0.515 (+0.07%) 01/14/21 BlackRock reports Q4 adjusted EPS $10.18, consensus $9.14 01/13/21 Notable companies reporting before tomorrow's open 10/13/20 BlackRock reports Q3 adjusted EPS $9.22, consensus $7.77 10/12/20 Notable companies reporting before tomorrow's open BTC Bitcoin $0.00 / + (+0.00%) 07/23/20 Fly Intel: What to watch in credit card space earnings reports BITCOIN Bitcoin $0.00 / + (+0.00%) 07/23/20 Fly Intel: What to watch in credit card space earnings reports 13 May BLK BTC BITCOIN BLK BlackRock $742.20 / +0.515 (+0.07%) 01/11/21 BlackRock selling stakes in sanctioned Chinese mobile companies, Bloomberg says 01/11/21 BlackRock pauses donations to public officials, Bloomberg reports 01/05/21 Rivian close to raising funds at $25B valuation, Bloomberg says 01/05/21 Rivian close to raising funds at $25B valuation, Bloomberg says BTC Bitcoin $0.00 / + (+0.00%) 01/20/21 Janet Yellen says cryptocurrencies used for illegal financing, BI says 12/17/20 Coinbase filed confidentially for IPO, Bloomberg says 11/27/20 Coinbase faces claims of discrimination from Black workers, NYT reports 11/24/20 MicroStrategy best way to own bitcoin in stock market, Citron says BITCOIN Bitcoin $0.00 / + (+0.00%) 12/17/20 Coinbase filed confidentially for IPO, Bloomberg says 11/27/20 Coinbase faces claims of discrimination from Black workers, NYT reports 10/22/20 PayPal in talks to acquire Bitcoin custodian BitGo, Bloomberg reports 09/29/20 Grayscale now controls roughly 2.4% of total Bitcoin supply, Cointelegraph says BLK BTC BITCOIN BLK BlackRock $742.20 / +0.515 (+0.07%) 01/14/21 Fly Intel: Pre-market Movers 12/06/20 Opening Day: Kinnate Biopharma soars in trading debut 10/13/20 Fly Intel: Wall Street's top stories for Tuesday 10/13/20 Fly Intel: Wall Street's top stories at midday BTC Bitcoin $0.00 / + (+0.00%) 01/15/21 The Intersection: Crypto and Wall Street This Week 01/08/21 The Intersection: Crypto and Wall Street This Week 12/18/20 The Intersection: Crypto and Wall Street This Week 12/17/20 Fly Intel: Wall Street's top stories for Thursday BITCOIN Bitcoin $0.00 / + (+0.00%) 01/15/21 The Intersection: Crypto and Wall Street This Week 01/08/21 The Intersection: Crypto and Wall Street This Week 12/18/20 The Intersection: Crypto and Wall Street This Week 12/17/20 Fly Intel: Wall Street's top stories for Thursday 02/24/21 22nd Annual Virtual Financial Services Forum BLK BLK BlackRock $742.20 / +0.515 (+0.07%) 10/13/20 Early notable gainers among liquid option names on October 13th
Hot Stocks	Gap's Athleta adds extended sizing to 350 styles in its 200 stores, online » 12:57 01/21/21 01/21 12:57 01/21/21 12:57 GPS Gap $22.89 / +0.66 (+2.97%) Gap's Athleta unit… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options GPS Gap $22.89 / +0.66 (+2.97%) 11/25/20 Gap falls -19.4% 11/25/20 Gap falls -16.9% 11/25/20 Gap falls -18.2% 11/24/20 Gap drops 10% to $24.06 after Q3 earnings miss GPS Gap $22.89 / +0.66 (+2.97%) 07:34 Today Deutsche Bank Gap price target raised to $26 from $25 at Deutsche Bank 01/15/21 B. Riley Securities Gap price target lowered to $22 from $31 at B. Riley Securities 11/25/20 Fly Intel: Top five analyst downgrades 11/25/20 Baird Gap price target raised to $25 from $23 at Baird GPS Gap $22.89 / +0.66 (+2.97%) 11/24/20 Gap reports Q3 Old Navy SSS up 17% y/y 11/24/20 Gap sees Q4 net sales equal or slightly higher than last year, consensus $4.54B 11/24/20 Gap reports Q3 EPS 25c, consensus 32c 11/24/20 Notable companies reporting after market close GPS Gap $22.89 / +0.66 (+2.97%) 12/02/20 UPS imposes shipping restrictions on Gap, Nike, WSJ reports 10/20/20 Gap reviewing options for its Gap Europe business, Bloomberg says 10/20/20 Gap reviewing options for its Gap Europe business, Bloomberg says GPS Gap $22.89 / +0.66 (+2.97%) 11/25/20 Fly Intel: Wall Street's top stories for Wednesday 11/25/20 Fly Intel: Wall Street's top stories at midday 11/25/20 Ford, Gap downgrades among today's top calls on Wall Street 11/25/20 Fly Intel: Pre-market Movers GPS Gap $22.89 / +0.66 (+2.97%) 11/27/20 Notable open interest changes for November 27th 11/24/20 Gap options imply 9.2% move in share price post-earnings 11/23/20 Early notable gainers among liquid option names on November 23rd 10/21/20 Largest borrow rate increases among liquid names

Recommendations	Village Farms price target raised to $22 from $13 at Roth Capital » 12:52 01/21/21 01/21 12:52 01/21/21 12:52 VFF Village Farms $12.44 / -0.39 (-3.04%) Roth Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Events Options VFF Village Farms $12.44 / -0.39 (-3.04%) 12/24/20 Village Farms not aware of 'material, undisclosed' info to account for trading 12/17/20 Village Farms: Pure Sunfarms enters partnership agreement with White Rabbit 12/04/20 Village Farms: DutchCanGrow does not receive cannabis production license 11/25/20 Village Farms' Pure Sunfarms enters agreement with Medical Cannabis by Shoppers VFF Village Farms $12.44 / -0.39 (-3.04%) 01/19/21 Craig-Hallum Village Farms price target raised to $25 from $10 at Craig-Hallum 12/24/20 Raymond James Raymond James says Village Farms situated well for cannabis sector consolidation 11/02/20 Raymond James Village Farms upgraded to Strong Buy from Outperform at Raymond James 09/14/20 Alliance Global Partners Village Farms price target raised to C$16 from C$14 at Alliance Global Partners VFF Village Farms $12.44 / -0.39 (-3.04%) 12/24/20 Fly Intel: Wall Street's top stories for Thursday 09/10/20 Rising High: Aurora Cannabis, Cronos Group appoint new CEOs 03/15/21 33rd Annual Roth Virtual Conference VFF Village Farms $12.44 / -0.39 (-3.04%) 01/14/21 Largest borrow rate increases among liquid names 01/07/21 Largest borrow rate increases among liquid names 12/23/20 Village Farms International call volume above normal and directionally bullish 12/18/20 Largest borrow rate increases among liquid names
Hot Stocks	Corteva confirms receipt of Starboard's intent to nominate directors » 12:52 01/21/21 01/21 12:52 01/21/21 12:52 CTVA Corteva $42.84 / -0.83 (-1.90%) Corteva confirmed receipt… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events CTVA Corteva $42.84 / -0.83 (-1.90%) 07:43 Today Starboard confirms nomination of eight candidates to Corteva's board 01/19/21 Matrix Service subsidiary awarded construction of water facility by Corteva 01/04/21 Corteva welcomes new Chief Technology Officer Sam Eathington 12/23/20 Tyson Foods appoints Megan Britt as VP, investor relations CTVA Corteva $42.84 / -0.83 (-1.90%) 05:12 Today Redburn Corteva downgraded to Neutral from Buy at Redburn 01/19/21 Deutsche Bank Corteva named 'Catalyst Call: Buy Idea' at Deutsche Bank 01/08/21 Deutsche Bank Corteva price target raised to $50 from $40 at Deutsche Bank 12/18/20 Susquehanna Corteva downgraded to Neutral from Positive at Susquehanna CTVA Corteva $42.84 / -0.83 (-1.90%) 11/04/20 Corteva backs FY20 operating EPS view $1.25-$1.45, consensus $1.38 11/04/20 Corteva reports Q3 adjusted EPS (39c), consensus (42c) 11/04/20 Notable companies reporting after market close 08/05/20 Corteva sees FY20 operating EPS $1.25-$1.45, consensus $1.40 CTVA Corteva $42.84 / -0.83 (-1.90%) 07:15 Today Starboard wants to take control of Corteva's board, replace CEO, WSJ reports 11/19/20 Corteva board backs CEO amid pressure from Starboard, Reuters says 10/09/20 Starboard makes new bets on Corteva, ON Semiconductor, Reuters reports 02/04/21 Corteva - CTVA
Recommendations	Lundin Mining price target raised to C$13.50 from C$13 at BMO Capital » 12:48 01/21/21 01/21 12:48 01/21/21 12:48 LUNMF Lundin Mining $0.00 / + (+0.00%) BMO Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research LUNMF Lundin Mining $0.00 / + (+0.00%) 01/15/21 Raymond James Lundin Mining price target raised to C$12 from C$8.50 at Raymond James 01/14/21 JPMorgan Lundin Mining price target raised to SEK 82 from SEK 61 at JPMorgan 01/13/21 Deutsche Bank Lundin Mining initiated with a Buy at Deutsche Bank 01/11/21 Scotiabank Lundin Mining price target raised to C$14 from C$9.50 at Scotiabank
Recommendations	Lithium Americas price target raised to C$20 from C$13 at BMO Capital » 12:47 01/21/21 01/21 12:47 01/21/21 12:47 LAC Lithium Americas $22.32 / +0.1 (+0.45%) BMO Capital analyst Joel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options LAC Lithium Americas $22.32 / +0.1 (+0.45%) 01/20/21 Lithium Americas falls -17.8% 01/20/21 Lithium Americas falls -13.9% 01/20/21 Lithium Americas falls -14.9% 01/20/21 Lithium Americas trading resumes LAC Lithium Americas $22.32 / +0.1 (+0.45%) 06:55 Today BMO Capital Lithium Americas price target raised to C$20 from C$13 at BMO Capital 01/06/21 Canaccord Lithium Americas price target raised to C$20 from C$11.50 at Canaccord 12/23/20 Stifel Stifel starts Lithium Americas with Buy, sees 'attractive upside' 12/22/20 Stifel Lithium Americas initiated with a Buy at Stifel LAC Lithium Americas $22.32 / +0.1 (+0.45%) 08/14/20 Lithium Americas reports Q2 EPS (7c) vs. (7c) last year 20 Jan LAC Lithium Americas $22.32 / +0.1 (+0.45%) 01/19/21 Fly Intel: After-Hours Movers 12/22/20 Fly Intel: After-Hours Movers 09/23/20 Tesla, lithium names under pressure as Wall Street digests Battery Day LAC Lithium Americas $22.32 / +0.1 (+0.45%) 08:45 Today Largest borrow rate increases among liquid names 01/13/21 Lithium Americas call volume above normal and directionally bullish 12/23/20 Unusually active option classes on open December 23rd 12/22/20 Lithium Americas call volume above normal and directionally bullish
Recommendations	Birchcliff Energy price target raised to C$2.85 from C$2.75 at BMO Capital » 12:46 01/21/21 01/21 12:46 01/21/21 12:46 BIREF Birchcliff Energy $0.00 / + (+0.00%) BMO Capital analyst Randy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research BIREF Birchcliff Energy $0.00 / + (+0.00%) 12:34 Today Canaccord Birchcliff Energy price target raised to C$3 from C$2.75 at Canaccord 12:05 Today National Bank Birchcliff Energy price target raised to C$3.50 from C$3 at National Bank 11:49 Today Stifel Birchcliff Energy price target raised to C$3.25 from C$3 at Stifel 11:19 Today Raymond James Birchcliff Energy price target raised to C$3.50 from C$3.25 at Raymond James

Recommendations	Uranium Royalty price target raised to C$1.80 from C$1.60 at Canaccord » 12:45 01/21/21 01/21 12:45 01/21/21 12:45 URCCF Uranium Royalty $0.00 / + (+0.00%) Canaccord analyst Katie… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research URCCF Uranium Royalty $0.00 / + (+0.00%) 01/04/21 H.C. Wainwright Uranium Royalty initiated with a Buy at H.C. Wainwright
Options	Nano X Imaging call volume above normal and directionally bullish » 12:45 01/21/21 01/21 12:45 01/21/21 12:45 NNOX Nano-X Imaging $58.66 / +6.16 (+11.73%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options NNOX Nano-X Imaging $58.66 / +6.16 (+11.73%) 01/20/21 Nano-X Imaging appoints Jim Dara as COO, Ofir Koren as CTO 10/29/20 Nano-X Imaging signs with Ambra Health to enable image access, transfer 10/02/20 Nano-X Imaging soars 33% after announcing live technology demonstration 09/23/20 Nano-X Imaging appoints Gilad Yron as CBO NNOX Nano-X Imaging $58.66 / +6.16 (+11.73%) 09/15/20 Cantor Fitzgerald Cantor reiterates $70 target on Nano-X after 'unfounded' short report 09/15/20 Cantor Fitzgerald Nano-X Imaging concerns in short report unfounded, says Cantor Fitzgerald 09/15/20 Oppenheimer Nano-X Imaging initiated with a Perform at Oppenheimer 09/15/20 Berenberg Nano-X Imaging initiated with a Buy at Berenberg NNOX Nano-X Imaging $58.66 / +6.16 (+11.73%) 11/09/20 Nano-X Imaging reports Q3 EPS (29c), two est. (23c) 21 Aug NNOX Nano-X Imaging $58.66 / +6.16 (+11.73%) 09/22/20 Muddy Waters joins Citron in shorting Nano-X Imaging 09/17/20 Tilson says Citron's Left right about Nano-X Imaging, 'stock is worthless' NNOX Nano-X Imaging $58.66 / +6.16 (+11.73%) 10/02/20 Fly Intel: Wall Street's top stories for Friday 10/02/20 Fly Intel: Wall Street's top stories at midday 09/22/20 Fly Intel: Wall Street's top stories at midday 09/22/20 Fly Intel: Pre-market Movers NNOX Nano-X Imaging $58.66 / +6.16 (+11.73%) 01/04/21 Largest borrow rate increases among liquid names 10/07/20 Largest borrow rate increases among liquid names 09/29/20 Largest borrow rate increases among liquid names 09/23/20 Four new option listings and one option delisting on September 23rd
Recommendations	NexGen Energy price target raised to C$5 from C$4 at Canaccord » 12:43 01/21/21 01/21 12:43 01/21/21 12:43 NXE NexGen Energy $2.75 / -0.045 (-1.61%) Canaccord analyst Katie… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research NXE NexGen Energy $2.75 / -0.045 (-1.61%) 01/15/21 Raymond James NexGen Energy price target raised to C$5 from C$4.25 at Raymond James 09/04/20 Cormark NexGen Energy initiated with a Buy at Cormark 05/12/20 TD Securities NexGen Energy price target raised to C$3.25 from C$2.75 at TD Securities
Recommendations	Fission Uranium price target raised to C$0.55 from C$0.40 at Canaccord » 12:43 01/21/21 01/21 12:43 01/21/21 12:43 FCUUF Fission Uranium $0.00 / + (+0.00%) Canaccord analyst Katie… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Hot Stocks	Synchrony, Mattress Firm renew consumer financing strategic partnership » 12:42 01/21/21 01/21 12:42 01/21/21 12:42 SYF Synchrony $38.34 / -1.57 (-3.93%) Synchrony Financial… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options SYF Synchrony $38.34 / -1.57 (-3.93%) 01/13/21 Walgreens expands financial services in pact with Synchrony, Mastercard 01/12/21 Synchrony names Brian Doubles as CEO, succeeding Margaret Keane 11/16/20 Synchrony reports October net charge offs 3.2% vs. 4.2% last month 10/20/20 Synchrony says successfully launched Venmo program SYF Synchrony $38.34 / -1.57 (-3.93%) 01/19/21 JPMorgan Synchrony upgraded to Overweight with $46 target at JPMorgan 01/19/21 JPMorgan Synchrony upgraded to Overweight from Neutral at JPMorgan 01/06/21 Deutsche Bank Synchrony price target raised to $51 from $31 at Deutsche Bank 01/04/21 Wells Fargo Synchrony price target raised to $41 from $32 at Wells Fargo SYF Synchrony $38.34 / -1.57 (-3.93%) 11/02/20 Fly Intel: What to watch in PayPal earnings report 10/20/20 Synchrony reports Q3 EPS 52c, consensus 70c SYF Synchrony $38.34 / -1.57 (-3.93%) 11/30/20 Apple upgrade, Slack downgrade among today's top calls on Wall Street 10/20/20 Fly Intel: Wall Street's top stories for Tuesday 10/20/20 Fly Intel: Wall Street's top stories at midday 10/20/20 Fly Intel: Pre-market Movers 01/29/21 Synchrony - SYF SYF Synchrony $38.34 / -1.57 (-3.93%) 10/08/20 Synchrony call volume above normal and directionally bullish 09/09/20 Synchrony call volume above normal and directionally bullish 09/04/20 Early notable gainers among liquid option names on September 4th 09/02/20 Synchrony put volume heavy and directionally bearish

Recommendations	Denison Mines price target raised to C$1.10 from C$0.90 at Canaccord » 12:39 01/21/21 01/21 12:39 01/21/21 12:39 DNN Denison Mines $0.69 / -0.0552 (-7.43%) Canaccord analyst Katie… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate DNN Denison Mines $0.69 / -0.0552 (-7.43%) 12/01/20 Denison Mines announces decision to adopt freeze wall for Phoenix ISR mining 11/09/20 Denison Mines to resume Wheeler River formal environmental assessment process 10/28/20 Denison Mines completes ISR field program at Wheeler River 07/30/20 Denison Mines announces LCIA arbitration ruling in its favor, UI to pay $10M DNN Denison Mines $0.69 / -0.0552 (-7.43%) 01/15/21 Raymond James Denison Mines price target raised to C$1.15 from C$0.95 at Raymond James 01/05/21 TD Securities Denison Mines downgraded to Hold from Speculative Buy at TD Securities 12/14/20 Cantor Fitzgerald Cameco downgraded to Hold from Buy at Cantor Fitzgerald 10/15/20 TD Securities Denison Mines resumed with Speculative Buy from Hold at TD Securities 26 Mar
Recommendations	Birchcliff Energy price target raised to C$3 from C$2.75 at Canaccord » 12:34 01/21/21 01/21 12:34 01/21/21 12:34 BIREF Birchcliff Energy $0.00 / + (+0.00%) Canaccord analyst Anthony… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BIREF Birchcliff Energy $0.00 / + (+0.00%) 12:05 Today National Bank Birchcliff Energy price target raised to C$3.50 from C$3 at National Bank 11:49 Today Stifel Birchcliff Energy price target raised to C$3.25 from C$3 at Stifel 11:19 Today Raymond James Birchcliff Energy price target raised to C$3.50 from C$3.25 at Raymond James 10:38 Today TD Securities Birchcliff Energy price target raised to C$3 from C$2.50 at TD Securities
Recommendations	AGF Management price target raised to C$8 from C$7 at Desjardins » 12:33 01/21/21 01/21 12:33 01/21/21 12:33 AGFMF AGF Management $0.00 / + (+0.00%) Desjardins analyst Gary… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings AGFMF AGF Management $0.00 / + (+0.00%) 09/23/20 AGF Management, SAF Group extend partnership for private credit opportunities 09/01/20 AGF Management confirms close of Smith & Williamson merger 08/07/20 AGF Management reports total fee-earning AUM of $37B as of July 31 07/31/20 AGF Management says Smith & Williamson shareholders approve Tilney merger AGFMF AGF Management $0.00 / + (+0.00%) 01/14/21 CIBC AGF Management initiated with a Neutral at CIBC 09/24/20 RBC Capital AGF Management price target raised to C$6 from C$5.50 at RBC Capital 09/24/20 BMO Capital AGF Management price target raised to C$6 from C$5 at BMO Capital 09/24/20 Scotiabank AGF Management price target raised to C$6.25 from C$6 at Scotiabank AGFMF AGF Management $0.00 / + (+0.00%) 09/23/20 AGF Management reports Q3 adj. EPS 19c vs. 7c last year
On The Fly	Fly Intel: What to watch in IBM's earnings report » 12:29 01/21/21 01/21 12:29 01/21/21 12:29 IBM IBM $130.58 / +0.5 (+0.38%) , GS Goldman Sachs $289.39 / -1.07 (-0.37%) IBM (IBM) is scheduled to… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options IBM GS IBM IBM $130.58 / +0.5 (+0.38%) 01/19/21 IBM, Atos expand strategic global alliance for digital transformation 01/14/21 IBM to acquire Taos, terms not disclosed 01/14/21 Vonage names Jay Bellissimo as COO 01/11/21 IBM acquires 7Summits, terms not disclosed GS Goldman Sachs $289.39 / -1.07 (-0.37%) 01/19/21 Goldman Sachs: Investment banking backlog at near-record levels 01/19/21 Goldman Sachs evaluating whether more staff can be moved to strategic locations 01/19/21 Goldman Sachs plans to resume share repurchases this quarter 01/19/21 Goldman Sachs plans to accelerate pace of asset sales IBM GS IBM IBM $130.58 / +0.5 (+0.38%) 10/20/20 Morgan Stanley Morgan Stanley continues to view IBM as 'a 2022 stock' 10/20/20 Citi IBM is 'getting even more complex,' says Citi 10/20/20 BMO Capital IBM price target lowered to $138 from $140 at BMO Capital 10/09/20 Morgan Stanley IBM price target raised to $140 from $128 at Morgan Stanley GS Goldman Sachs $289.39 / -1.07 (-0.37%) 01/20/21 Credit Suisse Goldman Sachs price target raised to $345 from $325 at Credit Suisse 01/20/21 Evercore ISI Goldman Sachs price target raised to $325 from $288 at Evercore ISI 01/20/21 DA Davidson Goldman Sachs price target raised to $321 from $279 at DA Davidson 01/20/21 Wells Fargo Goldman Sachs price target raised to $335 from $320 at Wells Fargo IBM GS IBM IBM $130.58 / +0.5 (+0.38%) 10/19/20 IBM reports Q3 Cloud & Cognitive Software revenue $5.6B, up 7% 10/19/20 IBM reports Q3 adjusted EPS $2.58, consensus $2.58 10/19/20 Notable companies reporting after market close 10/08/20 IBM reports preliminary Q3 EPS $2.58, consensus $2.58 GS Goldman Sachs $289.39 / -1.07 (-0.37%) 01/19/21 Goldman Sachs reports Q4 EPS $12.08, consensus $7.47 01/18/21 Fly Intel: What to watch in next round of big banks' earnings reports 10/14/20 Goldman Sachs reports Q3 EPS $9.68, consensus $5.57 10/13/20 Notable companies reporting before tomorrow's open IBM GS IBM IBM $130.58 / +0.5 (+0.38%) 01/14/21 IBM buying cloud computing consultant Taos Mountain, WSJ reports 01/06/21 IBM restructuring sales organization, WSJ reports 11/25/20 IBM to eliminate 10,000 positions in Europe ahead of unit sale, Bloomberg says 10/11/20 IBM split might not mean speedy recovery, WSJ says GS Goldman Sachs $289.39 / -1.07 (-0.37%) 01/07/21 Goldman Sachs CEO: 'I'd be cautious' of stock market volatility, Axios reports 12/31/20 M&A activity rebounded into year-end to finish 2020 down just 5%, FT says 12/29/20 Toshiba holds emergency board meeting amid investor demands, FT reports 12/28/20 Goldman Sachs leads $65M financing in Echelon Fitness, Bloomberg says IBM GS IBM IBM $130.58 / +0.5 (+0.38%) 01/05/21 Fly Intel: Wall Street's top stories for Tuesday 01/05/21 Fly Intel: Wall Street's top stories at midday 10/20/20 Fly Intel: Wall Street's top stories for Tuesday 10/20/20 Fly Intel: Wall Street's top stories at midday GS Goldman Sachs $289.39 / -1.07 (-0.37%) 01/19/21 Fly Intel: Wall Street's top stories at midday 01/19/21 Fly Intel: Pre-market Movers 01/05/21 Fly Intel: Wall Street's top stories for Tuesday 01/05/21 Fly Intel: Wall Street's top stories at midday 02/11/21 Technology & Internet Virtual Conference 02/24/21 22nd Annual Virtual Financial Services Forum 03/25/21 REITwise 2021 Virtual Conference 17:00 Today IBM - IBM IBM GS IBM IBM $130.58 / +0.5 (+0.38%) 01/05/21 Unusually active option classes on open January 5th 10/30/20 IBM call volume above normal and directionally bullish 10/19/20 IBM options imply 6.1% move in share price post-earnings 10/08/20 Early notable gainers among liquid option names on October 8th GS Goldman Sachs $289.39 / -1.07 (-0.37%) 01/13/21 Unusual call flow in option market yesterday 01/12/21 Short term 300 strike calls in Goldman Sachs see early action 01/07/21 Goldman Sachs call volume above normal and directionally bullish 12/23/20 Unusually active option classes on open December 23rd
Options	Boston Scientific call volume above normal and directionally bullish » 12:25 01/21/21 01/21 12:25 01/21/21 12:25 BSX Boston Scientific $37.40 / +0.75 (+2.05%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options BSX Boston Scientific $37.40 / +0.75 (+2.05%) 06:59 Today Boston Scientific to acquire Preventice Solutions for $925M in cash upfront 01/11/21 Boston Scientific announces Lotus Edge recall, sees $225M-$300M of charges 12/14/20 Boston Scientific says stipulation of dismissal filed in Nevro patent case 12/14/20 Nevro to conclude its Boston Scientific lawsuit in DC area BSX Boston Scientific $37.40 / +0.75 (+2.05%) 01/13/21 Piper Sandler MCIT finalized rule 'important win' for medical technology, says Piper Sandler 01/12/21 Piper Sandler Piper says Boston Scientific pullback an opportunity to build positions 12/23/20 Piper Sandler Boston Scientific a name to own at current share levels, says Piper Sandler 12/15/20 Goldman Sachs Boston Scientific downgraded to Buy from Conviction Buy at Goldman Sachs BSX Boston Scientific $37.40 / +0.75 (+2.05%) 01/12/21 Boston Scientific sees FY20 revenue $9.91B, consensus $10.08B 01/12/21 Boston Scientific reports preliminary Q4 revenue $2.71B, consensus $2.86B 10/28/20 Boston Scientific reports Q3 adj. EPS 37c, consensus 25c 10/27/20 Notable companies reporting before tomorrow's open 22 May BSX Boston Scientific $37.40 / +0.75 (+2.05%) 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday 01/12/21 Fly Intel: Pre-market Movers 10/28/20 Fly Intel: Pre-market Movers 02/03/21 Boston Scientific - BSX BSX Boston Scientific $37.40 / +0.75 (+2.05%) 10/14/20 Boston Scientific put volume heavy and directionally bearish 10/07/20 Boston Scientific put volume heavy and directionally bearish 08/31/20 Boston Scientific put volume heavy and directionally bearish 08/21/20 Boston Scientific call volume above normal and directionally bullish

Events

Earnings calls, analyst events, roadshows and more

HOMB
Today at 14:00

Home Bancshares - HOMB Conference Calls
SASR
Today at 14:00

Sandy Spring Bancorp - SASR Conference Calls
Today at 14:00

Enterprise & Cloud Infrastructure Industry Meetings
TEVA ...
Today at 14:00

Healthcare Industry Meetings
AXSM ...
Today at 15:00

Biotechnology Industry Meetings
PRCH
Today at 15:30

Porch.com - PRCH Conference Calls
Today at 16:00

Autos & Auto Parts Industry Meetings
STX
Today at 16:30

Seagate - STX Conference Calls
IDXG
Today at 16:30

Interpace Biosciences - IDXG Conference Calls
TENX
Today at 16:30

Tenax Therapeutics - TENX Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley Priced at: $25.50 700K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush Priced at: $13.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen Priced at: $26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities Priced at: $22.50 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright Priced at: $91.00 1.923M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading Priced at: $8.50 11.765M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler Priced at: $7.00 14.286M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel Priced at: $28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse Priced at: $66.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink Priced at: $24.75 4.85M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS Priced at: $66.00 3.788M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INO X INO Inovio Spot Secondary Managers: BofA, Jefferies & Cantor Fitzgerald, Oppenheimer Priced at: $8.50 2.655M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ONCS X ONCS OncoSec Spot Secondary Managers: BTIG Priced at: $5.45 7.71M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.30 7.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies $42.25 17.5M Shares CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen, & Stifel, Wedbush, Academy Securities $37.73 7.5M Shares DCBO X DCBO Docebo Secondary Managers: Morgan Stanley, Goldman Sachs & Canaccord $70.51 3.65M Shares NVTA X NVTA Invitae Secondary Managers: JPMorgan, Morgan Stanley, Cowen & SVB Leerink $56.93 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SI X SI Silvergate Capital Secondary Managers: Goldman Sachs, Keefe Bruyette & Canaccord, Compass Point, Craig-Hallum $66.43 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Sutro Biopharma's saw 'encouraging' phase 1 data for STRO-002 in ovarian cancer

TODAY'S FREE FLY STORIES

Get Full Fly Access